Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Praelolide, a potent Nrf2 activator, disrupts Keap1-Nrf2 protein-protein interactions through noncovalent binding to Keap1, inhibiting osteoclastogenesis and the production of reactive oxygen species (ROS). With its potential in osteoclastogenic bone disease research, Praelolide presents a promising avenue for therapeutic exploration.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | お問い合わせ | ¥ 349,000 |
50 mg | お問い合わせ | ¥ 454,500 |
100 mg | お問い合わせ | ¥ 574,000 |
説明 | Praelolide, a potent Nrf2 activator, disrupts Keap1-Nrf2 protein-protein interactions through noncovalent binding to Keap1, inhibiting osteoclastogenesis and the production of reactive oxygen species (ROS). With its potential in osteoclastogenic bone disease research, Praelolide presents a promising avenue for therapeutic exploration. |
分子量 | 599.02 |
分子式 | C28H35ClO12 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Praelolide Inhibitor inhibitor inhibit